E. Ilett

Oncolytic reovirus enhances rituximab-mediated antibody-dependent cellular cytotoxicity against chronic lymphocytic leukaemia

M. Coffey, A. Melcher, G. Scott, 2015, Leukemia.

The evolving role of dendritic cells in cancer therapy

E. Ilett, A. Melcher, Rjd Prestwich, 2010, Expert opinion on biological therapy.

Lymphokine-activated killer and dendritic cell carriage enhances oncolytic reovirus therapy for ovarian cancer by overcoming antibody neutralization in ascites

G. Hall, M. Coffey, A. Melcher, 2013, International journal of cancer.